Home / Rivaroxaban / Canada
CA ATC B01AF01 · updated 2 Nov 2026
Rivaroxaban shortage in Canada
Is there a Rivaroxaban shortage in Canada?
Yes. As of 2 Nov 2026, 1 Rivaroxaban product is reported short in Canada, the first since 10 Jun 2025. The company estimate for the return is 30 Nov 2026. Main reason: manufacturing problem.
Also short in United States, Germany, France, Italy, Spain, Ireland, Austria, Belgium, Switzerland, Czechia, Sweden, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEVA-RIVAROXABAN (3 x 10) | TEVA CANADA LIMITED | 10 Jun 2025 | 30 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.